nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—CYP19A1—seminiferous tubule of testis—alcohol dependence	0.0472	0.189	CbGeAlD
Cyproterone acetate—AR—seminiferous tubule of testis—alcohol dependence	0.0418	0.168	CbGeAlD
Cyproterone acetate—CYP19A1—semen—alcohol dependence	0.0261	0.105	CbGeAlD
Cyproterone acetate—AR—semen—alcohol dependence	0.0231	0.0926	CbGeAlD
Cyproterone acetate—NR3C1—nerve—alcohol dependence	0.00806	0.0323	CbGeAlD
Cyproterone acetate—CYP19A1—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00732	0.0945	CbGpPWpGaD
Cyproterone acetate—CYP19A1—forebrain—alcohol dependence	0.00521	0.0209	CbGeAlD
Cyproterone acetate—AR—forebrain—alcohol dependence	0.00461	0.0185	CbGeAlD
Cyproterone acetate—AR—adrenal cortex—alcohol dependence	0.00427	0.0171	CbGeAlD
Cyproterone acetate—CYP19A1—gonad—alcohol dependence	0.004	0.016	CbGeAlD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00391	0.0505	CbGpPWpGaD
Cyproterone acetate—AR—cardiovascular system—alcohol dependence	0.0039	0.0156	CbGeAlD
Cyproterone acetate—AR—gonad—alcohol dependence	0.00354	0.0142	CbGeAlD
Cyproterone acetate—CYP19A1—blood—alcohol dependence	0.00348	0.014	CbGeAlD
Cyproterone acetate—NR3C1—brainstem—alcohol dependence	0.00346	0.0139	CbGeAlD
Cyproterone acetate—NR3C1—forebrain—alcohol dependence	0.00334	0.0134	CbGeAlD
Cyproterone acetate—Rash maculo-papular—Acamprosate—alcohol dependence	0.00325	0.00483	CcSEcCtD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.00324	0.0418	CbGpPWpGaD
Cyproterone acetate—AR—digestive system—alcohol dependence	0.00324	0.013	CbGeAlD
Cyproterone acetate—Cyst—Citalopram—alcohol dependence	0.00321	0.00476	CcSEcCtD
Cyproterone acetate—Abnormal vision—Acamprosate—alcohol dependence	0.00312	0.00463	CcSEcCtD
Cyproterone acetate—Hyperventilation—Citalopram—alcohol dependence	0.00311	0.00463	CcSEcCtD
Cyproterone acetate—NR3C1—adrenal cortex—alcohol dependence	0.00309	0.0124	CbGeAlD
Cyproterone acetate—AR—blood—alcohol dependence	0.00308	0.0124	CbGeAlD
Cyproterone acetate—Thrombosis—Citalopram—alcohol dependence	0.00303	0.0045	CcSEcCtD
Cyproterone acetate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR7—alcohol dependence	0.00303	0.039	CbGpPWpGaD
Cyproterone acetate—CYP19A1—endocrine gland—alcohol dependence	0.00302	0.0121	CbGeAlD
Cyproterone acetate—Phlebitis—Acamprosate—alcohol dependence	0.00301	0.00447	CcSEcCtD
Cyproterone acetate—Thrombophlebitis—Acamprosate—alcohol dependence	0.003	0.00445	CcSEcCtD
Cyproterone acetate—Diabetes mellitus—Acamprosate—alcohol dependence	0.00298	0.00443	CcSEcCtD
Cyproterone acetate—Eczema—Acamprosate—alcohol dependence	0.00289	0.00429	CcSEcCtD
Cyproterone acetate—CYP19A1—testis—alcohol dependence	0.00288	0.0116	CbGeAlD
Cyproterone acetate—Phlebitis—Naltrexone—alcohol dependence	0.00285	0.00423	CcSEcCtD
Cyproterone acetate—Sleep disorder—Naltrexone—alcohol dependence	0.00284	0.00421	CcSEcCtD
Cyproterone acetate—CYP19A1—nervous system—alcohol dependence	0.00283	0.0113	CbGeAlD
Cyproterone acetate—NR3C1—cardiovascular system—alcohol dependence	0.00282	0.0113	CbGeAlD
Cyproterone acetate—Libido decreased—Acamprosate—alcohol dependence	0.0028	0.00416	CcSEcCtD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.00276	0.0356	CbGpPWpGaD
Cyproterone acetate—Dermatitis exfoliative—Acamprosate—alcohol dependence	0.00275	0.00409	CcSEcCtD
Cyproterone acetate—NR3C1—pancreas—alcohol dependence	0.00274	0.011	CbGeAlD
Cyproterone acetate—CYP19A1—liver—alcohol dependence	0.00272	0.0109	CbGeAlD
Cyproterone acetate—CYP19A1—central nervous system—alcohol dependence	0.00272	0.0109	CbGeAlD
Cyproterone acetate—AR—endocrine gland—alcohol dependence	0.00267	0.0107	CbGeAlD
Cyproterone acetate—Cardiac failure—Acamprosate—alcohol dependence	0.00266	0.00395	CcSEcCtD
Cyproterone acetate—Libido decreased—Naltrexone—alcohol dependence	0.00265	0.00393	CcSEcCtD
Cyproterone acetate—Hot flush—Naltrexone—alcohol dependence	0.00262	0.0039	CcSEcCtD
Cyproterone acetate—Menopausal symptoms—Naltrexone—alcohol dependence	0.0026	0.00386	CcSEcCtD
Cyproterone acetate—CYP19A1—Tryptophan metabolism—MAOB—alcohol dependence	0.0026	0.0335	CbGpPWpGaD
Cyproterone acetate—Endocrine disorder—Citalopram—alcohol dependence	0.00259	0.00384	CcSEcCtD
Cyproterone acetate—Disturbance in sexual arousal—Acamprosate—alcohol dependence	0.00257	0.00382	CcSEcCtD
Cyproterone acetate—NR3C1—gonad—alcohol dependence	0.00256	0.0103	CbGeAlD
Cyproterone acetate—Migraine—Acamprosate—alcohol dependence	0.00255	0.00379	CcSEcCtD
Cyproterone acetate—AR—testis—alcohol dependence	0.00255	0.0102	CbGeAlD
Cyproterone acetate—Acne—Citalopram—alcohol dependence	0.00255	0.00378	CcSEcCtD
Cyproterone acetate—AR—nervous system—alcohol dependence	0.0025	0.01	CbGeAlD
Cyproterone acetate—Breast pain—Citalopram—alcohol dependence	0.00246	0.00365	CcSEcCtD
Cyproterone acetate—Cardiovascular disorder—Citalopram—alcohol dependence	0.00244	0.00362	CcSEcCtD
Cyproterone acetate—Disturbance in sexual arousal—Naltrexone—alcohol dependence	0.00244	0.00362	CcSEcCtD
Cyproterone acetate—Blood creatinine increased—Acamprosate—alcohol dependence	0.00243	0.00361	CcSEcCtD
Cyproterone acetate—Migraine—Naltrexone—alcohol dependence	0.00242	0.00359	CcSEcCtD
Cyproterone acetate—AR—liver—alcohol dependence	0.00241	0.00967	CbGeAlD
Cyproterone acetate—AR—central nervous system—alcohol dependence	0.00241	0.00967	CbGeAlD
Cyproterone acetate—Liver function test abnormal—Acamprosate—alcohol dependence	0.0024	0.00356	CcSEcCtD
Cyproterone acetate—Skin discolouration—Citalopram—alcohol dependence	0.00237	0.00352	CcSEcCtD
Cyproterone acetate—Dysmenorrhoea—Citalopram—alcohol dependence	0.00236	0.0035	CcSEcCtD
Cyproterone acetate—Breast disorder—Acamprosate—alcohol dependence	0.00234	0.00348	CcSEcCtD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.00234	0.0302	CbGpPWpGaD
Cyproterone acetate—NR3C1—digestive system—alcohol dependence	0.00234	0.0094	CbGeAlD
Cyproterone acetate—Aspartate aminotransferase increased—Acamprosate—alcohol dependence	0.00234	0.00347	CcSEcCtD
Cyproterone acetate—Glossitis—Citalopram—alcohol dependence	0.00233	0.00345	CcSEcCtD
Cyproterone acetate—Alanine aminotransferase increased—Acamprosate—alcohol dependence	0.00229	0.0034	CcSEcCtD
Cyproterone acetate—Leukocytosis—Citalopram—alcohol dependence	0.00228	0.00339	CcSEcCtD
Cyproterone acetate—Asthma—Acamprosate—alcohol dependence	0.00224	0.00333	CcSEcCtD
Cyproterone acetate—NR3C1—blood—alcohol dependence	0.00223	0.00896	CbGeAlD
Cyproterone acetate—Fatigue—Disulfiram—alcohol dependence	0.00223	0.00332	CcSEcCtD
Cyproterone acetate—Aspartate aminotransferase increased—Naltrexone—alcohol dependence	0.00221	0.00328	CcSEcCtD
Cyproterone acetate—CYP19A1—Tryptophan metabolism—ALDH2—alcohol dependence	0.00221	0.0285	CbGpPWpGaD
Cyproterone acetate—NR3C1—midbrain—alcohol dependence	0.00221	0.00884	CbGeAlD
Cyproterone acetate—Pancreatitis—Acamprosate—alcohol dependence	0.0022	0.00327	CcSEcCtD
Cyproterone acetate—Gait disturbance—Citalopram—alcohol dependence	0.0022	0.00326	CcSEcCtD
Cyproterone acetate—Alanine aminotransferase increased—Naltrexone—alcohol dependence	0.00217	0.00322	CcSEcCtD
Cyproterone acetate—CYP19A1—brain—alcohol dependence	0.00216	0.00867	CbGeAlD
Cyproterone acetate—Pulmonary embolism—Citalopram—alcohol dependence	0.00214	0.00318	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—ADH6—alcohol dependence	0.00208	0.0268	CbGpPWpGaD
Cyproterone acetate—Pollakiuria—Acamprosate—alcohol dependence	0.00207	0.00308	CcSEcCtD
Cyproterone acetate—Sweating increased—Naltrexone—alcohol dependence	0.00207	0.00307	CcSEcCtD
Cyproterone acetate—Erectile dysfunction—Acamprosate—alcohol dependence	0.00207	0.00307	CcSEcCtD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.00206	0.0265	CbGpPWpGaD
Cyproterone acetate—Photosensitivity reaction—Acamprosate—alcohol dependence	0.00205	0.00304	CcSEcCtD
Cyproterone acetate—Weight increased—Acamprosate—alcohol dependence	0.00204	0.00303	CcSEcCtD
Cyproterone acetate—Fluid retention—Citalopram—alcohol dependence	0.00203	0.00302	CcSEcCtD
Cyproterone acetate—Weight decreased—Acamprosate—alcohol dependence	0.00203	0.00301	CcSEcCtD
Cyproterone acetate—Hyperglycaemia—Acamprosate—alcohol dependence	0.00202	0.00301	CcSEcCtD
Cyproterone acetate—Acute coronary syndrome—Acamprosate—alcohol dependence	0.00197	0.00293	CcSEcCtD
Cyproterone acetate—Myocardial infarction—Acamprosate—alcohol dependence	0.00196	0.00291	CcSEcCtD
Cyproterone acetate—Coma—Citalopram—alcohol dependence	0.00196	0.00291	CcSEcCtD
Cyproterone acetate—Rash maculo-papular—Citalopram—alcohol dependence	0.00195	0.00289	CcSEcCtD
Cyproterone acetate—Neoplasm—Citalopram—alcohol dependence	0.00194	0.00288	CcSEcCtD
Cyproterone acetate—NR3C1—endocrine gland—alcohol dependence	0.00194	0.00777	CbGeAlD
Cyproterone acetate—Weight increased—Naltrexone—alcohol dependence	0.00193	0.00287	CcSEcCtD
Cyproterone acetate—Weight decreased—Naltrexone—alcohol dependence	0.00192	0.00285	CcSEcCtD
Cyproterone acetate—Gynaecomastia—Citalopram—alcohol dependence	0.00192	0.00285	CcSEcCtD
Cyproterone acetate—Sweating—Acamprosate—alcohol dependence	0.00192	0.00285	CcSEcCtD
Cyproterone acetate—AR—brain—alcohol dependence	0.00191	0.00767	CbGeAlD
Cyproterone acetate—Haematuria—Acamprosate—alcohol dependence	0.00191	0.00283	CcSEcCtD
Cyproterone acetate—Abnormal vision—Citalopram—alcohol dependence	0.00187	0.00278	CcSEcCtD
Cyproterone acetate—Acute coronary syndrome—Naltrexone—alcohol dependence	0.00187	0.00277	CcSEcCtD
Cyproterone acetate—Asthenia—Disulfiram—alcohol dependence	0.00186	0.00276	CcSEcCtD
Cyproterone acetate—Myocardial infarction—Naltrexone—alcohol dependence	0.00185	0.00275	CcSEcCtD
Cyproterone acetate—NR3C1—testis—alcohol dependence	0.00185	0.00741	CbGeAlD
Cyproterone acetate—NR3C1—nervous system—alcohol dependence	0.00181	0.00727	CbGeAlD
Cyproterone acetate—Phlebitis—Citalopram—alcohol dependence	0.00181	0.00268	CcSEcCtD
Cyproterone acetate—Haemoglobin—Acamprosate—alcohol dependence	0.0018	0.00268	CcSEcCtD
Cyproterone acetate—Sleep disorder—Citalopram—alcohol dependence	0.0018	0.00267	CcSEcCtD
Cyproterone acetate—Hepatitis—Acamprosate—alcohol dependence	0.0018	0.00267	CcSEcCtD
Cyproterone acetate—Haemorrhage—Acamprosate—alcohol dependence	0.0018	0.00267	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Naltrexone—alcohol dependence	0.00179	0.00266	CcSEcCtD
Cyproterone acetate—Diabetes mellitus—Citalopram—alcohol dependence	0.00179	0.00266	CcSEcCtD
Cyproterone acetate—CYP19A1—Tryptophan metabolism—CYP2E1—alcohol dependence	0.00177	0.0228	CbGpPWpGaD
Cyproterone acetate—NR3C1—liver—alcohol dependence	0.00175	0.007	CbGeAlD
Cyproterone acetate—NR3C1—central nervous system—alcohol dependence	0.00175	0.007	CbGeAlD
Cyproterone acetate—Eczema—Citalopram—alcohol dependence	0.00173	0.00257	CcSEcCtD
Cyproterone acetate—Hepatic failure—Citalopram—alcohol dependence	0.00173	0.00257	CcSEcCtD
Cyproterone acetate—Visual impairment—Acamprosate—alcohol dependence	0.00173	0.00257	CcSEcCtD
Cyproterone acetate—Haemolytic anaemia—Citalopram—alcohol dependence	0.00172	0.00256	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—ADH1A—alcohol dependence	0.00172	0.0222	CbGpPWpGaD
Cyproterone acetate—Dizziness—Disulfiram—alcohol dependence	0.00171	0.00254	CcSEcCtD
Cyproterone acetate—NR3C1—cerebellum—alcohol dependence	0.00171	0.00684	CbGeAlD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.0017	0.022	CbGpPWpGaD
Cyproterone acetate—Hepatitis—Naltrexone—alcohol dependence	0.0017	0.00252	CcSEcCtD
Cyproterone acetate—Libido decreased—Citalopram—alcohol dependence	0.00168	0.00249	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Naltrexone—alcohol dependence	0.00167	0.00248	CcSEcCtD
Cyproterone acetate—Hot flush—Citalopram—alcohol dependence	0.00166	0.00247	CcSEcCtD
Cyproterone acetate—Menopausal symptoms—Citalopram—alcohol dependence	0.00165	0.00245	CcSEcCtD
Cyproterone acetate—CYP19A1—Endogenous sterols—POMC—alcohol dependence	0.00165	0.0213	CbGpPWpGaD
Cyproterone acetate—Rash—Disulfiram—alcohol dependence	0.00163	0.00242	CcSEcCtD
Cyproterone acetate—Headache—Disulfiram—alcohol dependence	0.00162	0.00241	CcSEcCtD
Cyproterone acetate—Immune system disorder—Acamprosate—alcohol dependence	0.00162	0.00241	CcSEcCtD
Cyproterone acetate—Chills—Acamprosate—alcohol dependence	0.00161	0.00239	CcSEcCtD
Cyproterone acetate—Cardiac failure—Citalopram—alcohol dependence	0.00159	0.00237	CcSEcCtD
Cyproterone acetate—Cerebrovascular accident—Citalopram—alcohol dependence	0.00159	0.00236	CcSEcCtD
Cyproterone acetate—Eye disorder—Naltrexone—alcohol dependence	0.00159	0.00236	CcSEcCtD
Cyproterone acetate—Alopecia—Acamprosate—alcohol dependence	0.00159	0.00236	CcSEcCtD
Cyproterone acetate—Mental disorder—Acamprosate—alcohol dependence	0.00157	0.00234	CcSEcCtD
Cyproterone acetate—Malnutrition—Acamprosate—alcohol dependence	0.00156	0.00232	CcSEcCtD
Cyproterone acetate—Disturbance in sexual arousal—Citalopram—alcohol dependence	0.00154	0.00229	CcSEcCtD
Cyproterone acetate—Angiopathy—Naltrexone—alcohol dependence	0.00154	0.00229	CcSEcCtD
Cyproterone acetate—Immune system disorder—Naltrexone—alcohol dependence	0.00153	0.00228	CcSEcCtD
Cyproterone acetate—Tension—Acamprosate—alcohol dependence	0.00153	0.00228	CcSEcCtD
Cyproterone acetate—Affect lability—Citalopram—alcohol dependence	0.00153	0.00227	CcSEcCtD
Cyproterone acetate—Migraine—Citalopram—alcohol dependence	0.00153	0.00227	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Naltrexone—alcohol dependence	0.00153	0.00227	CcSEcCtD
Cyproterone acetate—Chills—Naltrexone—alcohol dependence	0.00152	0.00226	CcSEcCtD
Cyproterone acetate—Alopecia—Naltrexone—alcohol dependence	0.0015	0.00223	CcSEcCtD
Cyproterone acetate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—alcohol dependence	0.00149	0.0193	CbGpPWpGaD
Cyproterone acetate—Mental disorder—Naltrexone—alcohol dependence	0.00149	0.00221	CcSEcCtD
Cyproterone acetate—Malnutrition—Naltrexone—alcohol dependence	0.00148	0.0022	CcSEcCtD
Cyproterone acetate—Mood swings—Citalopram—alcohol dependence	0.00147	0.00219	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—ADH4—alcohol dependence	0.00146	0.0189	CbGpPWpGaD
Cyproterone acetate—Tension—Naltrexone—alcohol dependence	0.00145	0.00216	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Acamprosate—alcohol dependence	0.00145	0.00215	CcSEcCtD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.00145	0.0187	CbGpPWpGaD
Cyproterone acetate—Anaemia—Acamprosate—alcohol dependence	0.00144	0.00215	CcSEcCtD
Cyproterone acetate—Liver function test abnormal—Citalopram—alcohol dependence	0.00144	0.00213	CcSEcCtD
Cyproterone acetate—Agitation—Acamprosate—alcohol dependence	0.00144	0.00213	CcSEcCtD
Cyproterone acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.00143	0.0184	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.00141	0.0182	CbGpPWpGaD
Cyproterone acetate—Malaise—Acamprosate—alcohol dependence	0.00141	0.00209	CcSEcCtD
Cyproterone acetate—Breast disorder—Citalopram—alcohol dependence	0.00141	0.00209	CcSEcCtD
Cyproterone acetate—Syncope—Acamprosate—alcohol dependence	0.0014	0.00208	CcSEcCtD
Cyproterone acetate—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.0014	0.00208	CcSEcCtD
Cyproterone acetate—Leukopenia—Acamprosate—alcohol dependence	0.0014	0.00208	CcSEcCtD
Cyproterone acetate—NR3C1—brain—alcohol dependence	0.00139	0.00556	CbGeAlD
Cyproterone acetate—Loss of consciousness—Acamprosate—alcohol dependence	0.00137	0.00204	CcSEcCtD
Cyproterone acetate—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.00137	0.00204	CcSEcCtD
Cyproterone acetate—Muscular weakness—Citalopram—alcohol dependence	0.00137	0.00204	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Naltrexone—alcohol dependence	0.00137	0.00204	CcSEcCtD
Cyproterone acetate—Cough—Acamprosate—alcohol dependence	0.00136	0.00203	CcSEcCtD
Cyproterone acetate—Agitation—Naltrexone—alcohol dependence	0.00136	0.00202	CcSEcCtD
Cyproterone acetate—Asthma—Citalopram—alcohol dependence	0.00134	0.002	CcSEcCtD
Cyproterone acetate—Malaise—Naltrexone—alcohol dependence	0.00133	0.00198	CcSEcCtD
Cyproterone acetate—Syncope—Naltrexone—alcohol dependence	0.00133	0.00197	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.00132	0.00196	CcSEcCtD
Cyproterone acetate—Pancreatitis—Citalopram—alcohol dependence	0.00132	0.00196	CcSEcCtD
Cyproterone acetate—Discomfort—Acamprosate—alcohol dependence	0.00131	0.00195	CcSEcCtD
Cyproterone acetate—Sweating increased—Citalopram—alcohol dependence	0.00131	0.00195	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Naltrexone—alcohol dependence	0.0013	0.00193	CcSEcCtD
Cyproterone acetate—Cough—Naltrexone—alcohol dependence	0.00129	0.00192	CcSEcCtD
Cyproterone acetate—Shock—Acamprosate—alcohol dependence	0.00125	0.00186	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.00125	0.00186	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Acamprosate—alcohol dependence	0.00125	0.00185	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—ADH7—alcohol dependence	0.00125	0.0161	CbGpPWpGaD
Cyproterone acetate—Tachycardia—Acamprosate—alcohol dependence	0.00124	0.00185	CcSEcCtD
Cyproterone acetate—Discomfort—Naltrexone—alcohol dependence	0.00124	0.00185	CcSEcCtD
Cyproterone acetate—Pollakiuria—Citalopram—alcohol dependence	0.00124	0.00184	CcSEcCtD
Cyproterone acetate—Skin disorder—Acamprosate—alcohol dependence	0.00124	0.00184	CcSEcCtD
Cyproterone acetate—Erectile dysfunction—Citalopram—alcohol dependence	0.00124	0.00184	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—alcohol dependence	0.00123	0.0159	CbGpPWpGaD
Cyproterone acetate—Hyperhidrosis—Acamprosate—alcohol dependence	0.00123	0.00183	CcSEcCtD
Cyproterone acetate—Photosensitivity reaction—Citalopram—alcohol dependence	0.00123	0.00182	CcSEcCtD
Cyproterone acetate—Weight increased—Citalopram—alcohol dependence	0.00122	0.00182	CcSEcCtD
Cyproterone acetate—Weight decreased—Citalopram—alcohol dependence	0.00122	0.00181	CcSEcCtD
Cyproterone acetate—Anorexia—Acamprosate—alcohol dependence	0.00122	0.00181	CcSEcCtD
Cyproterone acetate—Hyperglycaemia—Citalopram—alcohol dependence	0.00121	0.0018	CcSEcCtD
Cyproterone acetate—Oedema—Naltrexone—alcohol dependence	0.00121	0.00179	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—GGT2—alcohol dependence	0.00119	0.0154	CbGpPWpGaD
Cyproterone acetate—Hypotension—Acamprosate—alcohol dependence	0.00119	0.00177	CcSEcCtD
Cyproterone acetate—Shock—Naltrexone—alcohol dependence	0.00119	0.00176	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Naltrexone—alcohol dependence	0.00118	0.00176	CcSEcCtD
Cyproterone acetate—Acute coronary syndrome—Citalopram—alcohol dependence	0.00118	0.00176	CcSEcCtD
Cyproterone acetate—Tachycardia—Naltrexone—alcohol dependence	0.00118	0.00175	CcSEcCtD
Cyproterone acetate—Myocardial infarction—Citalopram—alcohol dependence	0.00118	0.00175	CcSEcCtD
Cyproterone acetate—Skin disorder—Naltrexone—alcohol dependence	0.00117	0.00174	CcSEcCtD
Cyproterone acetate—Jaundice—Citalopram—alcohol dependence	0.00117	0.00174	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Naltrexone—alcohol dependence	0.00117	0.00173	CcSEcCtD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.00116	0.0149	CbGpPWpGaD
Cyproterone acetate—Anorexia—Naltrexone—alcohol dependence	0.00115	0.00171	CcSEcCtD
Cyproterone acetate—Sweating—Citalopram—alcohol dependence	0.00115	0.00171	CcSEcCtD
Cyproterone acetate—Haematuria—Citalopram—alcohol dependence	0.00114	0.0017	CcSEcCtD
Cyproterone acetate—Dyspnoea—Acamprosate—alcohol dependence	0.00114	0.00169	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Citalopram—alcohol dependence	0.00113	0.00168	CcSEcCtD
Cyproterone acetate—Dyspepsia—Acamprosate—alcohol dependence	0.00112	0.00167	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CHRM2—alcohol dependence	0.00111	0.0144	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Acamprosate—alcohol dependence	0.00111	0.00165	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.0011	0.00164	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—ADH1B—alcohol dependence	0.00109	0.0141	CbGpPWpGaD
Cyproterone acetate—Constipation—Acamprosate—alcohol dependence	0.00109	0.00162	CcSEcCtD
Cyproterone acetate—NR3C1—Circadian Clock—AVP—alcohol dependence	0.00109	0.014	CbGpPWpGaD
Cyproterone acetate—Haemoglobin—Citalopram—alcohol dependence	0.00108	0.00161	CcSEcCtD
Cyproterone acetate—Hepatitis—Citalopram—alcohol dependence	0.00108	0.0016	CcSEcCtD
Cyproterone acetate—Haemorrhage—Citalopram—alcohol dependence	0.00108	0.0016	CcSEcCtD
Cyproterone acetate—Dyspnoea—Naltrexone—alcohol dependence	0.00108	0.0016	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Citalopram—alcohol dependence	0.00106	0.00157	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Acamprosate—alcohol dependence	0.00105	0.00156	CcSEcCtD
Cyproterone acetate—Decreased appetite—Naltrexone—alcohol dependence	0.00105	0.00156	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Acamprosate—alcohol dependence	0.00104	0.00155	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.00104	0.00155	CcSEcCtD
Cyproterone acetate—Fatigue—Naltrexone—alcohol dependence	0.00104	0.00155	CcSEcCtD
Cyproterone acetate—Visual impairment—Citalopram—alcohol dependence	0.00104	0.00154	CcSEcCtD
Cyproterone acetate—Constipation—Naltrexone—alcohol dependence	0.00103	0.00153	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Citalopram—alcohol dependence	0.00102	0.00151	CcSEcCtD
Cyproterone acetate—Urticaria—Acamprosate—alcohol dependence	0.00101	0.00151	CcSEcCtD
Cyproterone acetate—Abdominal pain—Acamprosate—alcohol dependence	0.00101	0.0015	CcSEcCtD
Cyproterone acetate—Body temperature increased—Acamprosate—alcohol dependence	0.00101	0.0015	CcSEcCtD
Cyproterone acetate—Eye disorder—Citalopram—alcohol dependence	0.00101	0.00149	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Naltrexone—alcohol dependence	0.000994	0.00148	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000987	0.00147	CcSEcCtD
Cyproterone acetate—Angiopathy—Citalopram—alcohol dependence	0.000976	0.00145	CcSEcCtD
Cyproterone acetate—Immune system disorder—Citalopram—alcohol dependence	0.000972	0.00144	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Citalopram—alcohol dependence	0.00097	0.00144	CcSEcCtD
Cyproterone acetate—Chills—Citalopram—alcohol dependence	0.000966	0.00143	CcSEcCtD
Cyproterone acetate—Urticaria—Naltrexone—alcohol dependence	0.000959	0.00142	CcSEcCtD
Cyproterone acetate—Abdominal pain—Naltrexone—alcohol dependence	0.000954	0.00142	CcSEcCtD
Cyproterone acetate—Body temperature increased—Naltrexone—alcohol dependence	0.000954	0.00142	CcSEcCtD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000952	0.0123	CbGpPWpGaD
Cyproterone acetate—Alopecia—Citalopram—alcohol dependence	0.000951	0.00141	CcSEcCtD
Cyproterone acetate—Mental disorder—Citalopram—alcohol dependence	0.000943	0.0014	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Acamprosate—alcohol dependence	0.00094	0.0014	CcSEcCtD
Cyproterone acetate—Malnutrition—Citalopram—alcohol dependence	0.000937	0.00139	CcSEcCtD
Cyproterone acetate—Tension—Citalopram—alcohol dependence	0.000919	0.00137	CcSEcCtD
Cyproterone acetate—Asthenia—Acamprosate—alcohol dependence	0.000915	0.00136	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—MAOB—alcohol dependence	0.000905	0.0117	CbGpPWpGaD
Cyproterone acetate—Pruritus—Acamprosate—alcohol dependence	0.000902	0.00134	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Naltrexone—alcohol dependence	0.000889	0.00132	CcSEcCtD
Cyproterone acetate—Diarrhoea—Acamprosate—alcohol dependence	0.000873	0.0013	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Citalopram—alcohol dependence	0.000869	0.00129	CcSEcCtD
Cyproterone acetate—Anaemia—Citalopram—alcohol dependence	0.000866	0.00129	CcSEcCtD
Cyproterone acetate—Asthenia—Naltrexone—alcohol dependence	0.000866	0.00129	CcSEcCtD
Cyproterone acetate—Agitation—Citalopram—alcohol dependence	0.000861	0.00128	CcSEcCtD
Cyproterone acetate—Pruritus—Naltrexone—alcohol dependence	0.000854	0.00127	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CHRM2—alcohol dependence	0.000846	0.0109	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—SLC6A4—alcohol dependence	0.000845	0.0109	CbGpPWpGaD
Cyproterone acetate—Malaise—Citalopram—alcohol dependence	0.000845	0.00125	CcSEcCtD
Cyproterone acetate—Dizziness—Acamprosate—alcohol dependence	0.000843	0.00125	CcSEcCtD
Cyproterone acetate—Syncope—Citalopram—alcohol dependence	0.00084	0.00125	CcSEcCtD
Cyproterone acetate—Leukopenia—Citalopram—alcohol dependence	0.000839	0.00125	CcSEcCtD
Cyproterone acetate—Diarrhoea—Naltrexone—alcohol dependence	0.000826	0.00123	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Citalopram—alcohol dependence	0.000823	0.00122	CcSEcCtD
Cyproterone acetate—Cough—Citalopram—alcohol dependence	0.000817	0.00121	CcSEcCtD
Cyproterone acetate—Vomiting—Acamprosate—alcohol dependence	0.000811	0.0012	CcSEcCtD
Cyproterone acetate—Rash—Acamprosate—alcohol dependence	0.000804	0.00119	CcSEcCtD
Cyproterone acetate—Dermatitis—Acamprosate—alcohol dependence	0.000803	0.00119	CcSEcCtD
Cyproterone acetate—Headache—Acamprosate—alcohol dependence	0.000799	0.00119	CcSEcCtD
Cyproterone acetate—Dizziness—Naltrexone—alcohol dependence	0.000798	0.00119	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000792	0.00118	CcSEcCtD
Cyproterone acetate—Discomfort—Citalopram—alcohol dependence	0.000788	0.00117	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—ALDH2—alcohol dependence	0.000769	0.00993	CbGpPWpGaD
Cyproterone acetate—Vomiting—Naltrexone—alcohol dependence	0.000767	0.00114	CcSEcCtD
Cyproterone acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000765	0.00987	CbGpPWpGaD
Cyproterone acetate—Oedema—Citalopram—alcohol dependence	0.000765	0.00114	CcSEcCtD
Cyproterone acetate—Rash—Naltrexone—alcohol dependence	0.000761	0.00113	CcSEcCtD
Cyproterone acetate—Dermatitis—Naltrexone—alcohol dependence	0.00076	0.00113	CcSEcCtD
Cyproterone acetate—Nausea—Acamprosate—alcohol dependence	0.000758	0.00113	CcSEcCtD
Cyproterone acetate—Headache—Naltrexone—alcohol dependence	0.000756	0.00112	CcSEcCtD
Cyproterone acetate—AR—FOXA1 transcription factor network—EP300—alcohol dependence	0.000756	0.00975	CbGpPWpGaD
Cyproterone acetate—Shock—Citalopram—alcohol dependence	0.000752	0.00112	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Citalopram—alcohol dependence	0.00075	0.00111	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Citalopram—alcohol dependence	0.000749	0.00111	CcSEcCtD
Cyproterone acetate—Tachycardia—Citalopram—alcohol dependence	0.000746	0.00111	CcSEcCtD
Cyproterone acetate—Skin disorder—Citalopram—alcohol dependence	0.000743	0.0011	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Citalopram—alcohol dependence	0.000739	0.0011	CcSEcCtD
Cyproterone acetate—Anorexia—Citalopram—alcohol dependence	0.000729	0.00108	CcSEcCtD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—EP300—alcohol dependence	0.000717	0.00925	CbGpPWpGaD
Cyproterone acetate—Nausea—Naltrexone—alcohol dependence	0.000717	0.00106	CcSEcCtD
Cyproterone acetate—Hypotension—Citalopram—alcohol dependence	0.000714	0.00106	CcSEcCtD
Cyproterone acetate—Dyspnoea—Citalopram—alcohol dependence	0.000682	0.00101	CcSEcCtD
Cyproterone acetate—Dyspepsia—Citalopram—alcohol dependence	0.000673	0.001	CcSEcCtD
Cyproterone acetate—Decreased appetite—Citalopram—alcohol dependence	0.000665	0.000987	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Citalopram—alcohol dependence	0.00066	0.00098	CcSEcCtD
Cyproterone acetate—Fatigue—Citalopram—alcohol dependence	0.000659	0.000979	CcSEcCtD
Cyproterone acetate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—alcohol dependence	0.000659	0.0085	CbGpPWpGaD
Cyproterone acetate—Constipation—Citalopram—alcohol dependence	0.000654	0.000971	CcSEcCtD
Cyproterone acetate—AR—Regulation of Androgen receptor activity—EP300—alcohol dependence	0.000651	0.0084	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—SLC6A4—alcohol dependence	0.000641	0.00827	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—MAOA—alcohol dependence	0.000636	0.0082	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Citalopram—alcohol dependence	0.00063	0.000936	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Citalopram—alcohol dependence	0.000625	0.000929	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—AVP—alcohol dependence	0.000623	0.00804	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.00062	0.008	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—CYP2E1—alcohol dependence	0.000615	0.00794	CbGpPWpGaD
Cyproterone acetate—Urticaria—Citalopram—alcohol dependence	0.000607	0.000902	CcSEcCtD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000606	0.00783	CbGpPWpGaD
Cyproterone acetate—Body temperature increased—Citalopram—alcohol dependence	0.000604	0.000898	CcSEcCtD
Cyproterone acetate—Abdominal pain—Citalopram—alcohol dependence	0.000604	0.000898	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—GGT1—alcohol dependence	0.000565	0.00729	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Citalopram—alcohol dependence	0.000563	0.000837	CcSEcCtD
Cyproterone acetate—Asthenia—Citalopram—alcohol dependence	0.000549	0.000815	CcSEcCtD
Cyproterone acetate—Pruritus—Citalopram—alcohol dependence	0.000541	0.000804	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—POMC—alcohol dependence	0.000525	0.00678	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Citalopram—alcohol dependence	0.000523	0.000777	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—HTR2A—alcohol dependence	0.000518	0.00669	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—MAOA—alcohol dependence	0.000506	0.00653	CbGpPWpGaD
Cyproterone acetate—Dizziness—Citalopram—alcohol dependence	0.000506	0.000751	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—EP300—alcohol dependence	0.000494	0.00638	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—CCAR1—alcohol dependence	0.000494	0.00637	CbGpPWpGaD
Cyproterone acetate—Vomiting—Citalopram—alcohol dependence	0.000486	0.000722	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—MAOA—alcohol dependence	0.000482	0.00622	CbGpPWpGaD
Cyproterone acetate—Rash—Citalopram—alcohol dependence	0.000482	0.000716	CcSEcCtD
Cyproterone acetate—Dermatitis—Citalopram—alcohol dependence	0.000482	0.000715	CcSEcCtD
Cyproterone acetate—NR3C1—Circadian Clock—EP300—alcohol dependence	0.00048	0.00619	CbGpPWpGaD
Cyproterone acetate—Headache—Citalopram—alcohol dependence	0.000479	0.000711	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—AVP—alcohol dependence	0.000473	0.0061	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—alcohol dependence	0.000468	0.00605	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—EP300—alcohol dependence	0.000464	0.00599	CbGpPWpGaD
Cyproterone acetate—Nausea—Citalopram—alcohol dependence	0.000454	0.000675	CcSEcCtD
Cyproterone acetate—AR—Androgen receptor signaling pathway—EP300—alcohol dependence	0.00043	0.00555	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—EP300—alcohol dependence	0.000395	0.0051	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—HTR2A—alcohol dependence	0.000393	0.00507	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—CCAR1—alcohol dependence	0.000375	0.00484	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ADH6—alcohol dependence	0.000355	0.00459	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—alcohol dependence	0.000352	0.00454	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—EP300—alcohol dependence	0.000348	0.0045	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—POMC—alcohol dependence	0.000329	0.00425	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ADH1A—alcohol dependence	0.000295	0.0038	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—EP300—alcohol dependence	0.000282	0.00364	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—EP300—alcohol dependence	0.000275	0.00354	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ADH4—alcohol dependence	0.00025	0.00323	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—EP300—alcohol dependence	0.000243	0.00313	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	0.000234	0.00301	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.000217	0.0028	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ADH7—alcohol dependence	0.000213	0.00275	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—EP300—alcohol dependence	0.000208	0.00269	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GGT2—alcohol dependence	0.000204	0.00263	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ADH1B—alcohol dependence	0.000187	0.00241	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—MAOB—alcohol dependence	0.000155	0.002	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ALDH2—alcohol dependence	0.000132	0.0017	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	0.000126	0.00163	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GOT2—alcohol dependence	0.000112	0.00144	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP2E1—alcohol dependence	0.000105	0.00136	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GOT1—alcohol dependence	9.66e-05	0.00125	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GGT1—alcohol dependence	9.66e-05	0.00125	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—MAOA—alcohol dependence	8.65e-05	0.00112	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	8.39e-05	0.00108	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—POMC—alcohol dependence	5.63e-05	0.000727	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—EP300—alcohol dependence	3.74e-05	0.000482	CbGpPWpGaD
